Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,107 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Active, Not Recruiting

CINC424A2X01B Rollover Protocol

NCT02386800

Conditions
Acute Myeloid Leukemia, Anemia, Anemia, Hemolytic, +31 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Wooloongabba, Queensland, Australia
  • Novartis Investigative Site Bedford Park, South Australia, Australia
View all 97 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis

NCT04562870

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
  • Rocky Mountain Cancer Centers, LLP Aurora, Colorado, United States
  • Illinois Cancer Specialist Niles, Illinois, United States
  • Texas Oncology - Northeast Texas Tyler, Texas, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

NCT00658814

Conditions
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, +24 more
Locations
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
View all 177 locations
View Trial Details
Active, Not Recruiting

Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

NCT03289910

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid Leukemia, +32 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Extended Access of Momelotinib in Adults With Myelofibrosis

NCT03441113

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Orange, California, United States
  • GSK Investigational Site Stanford, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
View all 112 locations
View Trial Details
Active, Not Recruiting

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

NCT05548062

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Novartis Investigative Site Alessandria, AL, Italy
  • Novartis Investigative Site Ancona, AN, Italy
  • Novartis Investigative Site Bari, BA, Italy
  • Novartis Investigative Site Bologna, BO, Italy
View all 33 locations
View Trial Details
Active, Not Recruiting

A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

NCT04971226

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists Pan Tallahassee, Florida, United States
  • University of Kentucky Lexington, Kentucky, United States
View all 110 locations
View Trial Details

Related conditions